Replies to post #370380 on Anavex Life Sciences Corp (AVXL)

[raja48185]

I am sure you know the drill - All AVXL investors have to wait.

Rett will be up for approval probably during the 1H of 2023 if everything goes as per plan. Actual approval depends on how long FDA sits on it assuming that Anavex gives them all the data that is necessary in the right format across various groups/sub groups with relevant analysis and there is no going back and forth.

I personally do not want to assume that approval is a given. The company has to complete the trial and then deliver results that are statistically and clinically significant. Still a long way to go and too early to start dreaming (IMO). Many on the board have been invested in the stock since 2015/2016 and a few even earlier to that.

Hoping for the best and still holding on to all of my shares (since 2015).